1-[benzoyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]-2-(3-fluorobenzoyl)cyclopropane-1-carboxylic acid
C23H22FNO6 — CID 70256110
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[benzoyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]-2-(3-fluorobenzoyl)cyclopropane-1-carboxylic acid
1-[benzoyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]-2-(3-fluorobenzoyl)cyclopropane-1-carboxylic acid (PubChem CID 70256110) has the molecular formula C23H22FNO6 and a molecular weight of 427.43 g/mol. Its IUPAC name is 1-[benzoyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]-2-(3-fluorobenzoyl)cyclopropane-1-carboxylic acid.
Molecular Properties
| Compound Name | 1-[benzoyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]-2-(3-fluorobenzoyl)cyclopropane-1-carboxylic acid |
|---|---|
| PubChem CID | 70256110 |
| Molecular Formula | C23H22FNO6 |
| Molecular Weight | 427.43 g/mol |
| Exact Mass | 427.14 |
| IUPAC Name | 1-[benzoyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]-2-(3-fluorobenzoyl)cyclopropane-1-carboxylic acid |
| SMILES | CC(C)(C)OC(=O)N(C(=O)c1ccccc1)C1(C(=O)O)CC1C(=O)c1cccc(F)c1 |
| InChI | InChI=1S/C23H22FNO6/c1-22(2,3)31-21(30)25(19(27)14-8-5-4-6-9-14)23(20(28)29)13-17(23)18(26)15-10-7-11-16(24)12-15/h4-12,17H,13H2,1-3H3,(H,28,29) |
| InChIKey | UQIRFJOWBLRRJC-UHFFFAOYSA-N |
| XLogP | 3.93 |
| TPSA | 100.98 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 427.43 |
| LogP ≤ 5 | 3.93 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 70256110 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.